The detection of prostate cancer based on ultrasound RF signal
The diagnosis of prostate cancer has been a challenging task. Compared with traditional diagnosis methods, the radiofrequency (RF) signal is not only non-invasive but also rich in microscopic lesion information. This paper proposes a novel and accurate method for detecting prostate cancer based on t...
Saved in:
Published in | Frontiers in oncology Vol. 12; p. 946965 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
12.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The diagnosis of prostate cancer has been a challenging task. Compared with traditional diagnosis methods, the radiofrequency (RF) signal is not only non-invasive but also rich in microscopic lesion information. This paper proposes a novel and accurate method for detecting prostate cancer based on the ultrasound RF signal.
Our approach is based on low-dimensional features in the frequency domain and high-throughput features in the spatial domain. The whole process could be divided into two parts: first, we calculate three feature maps from the ultrasound original RF signal, and 1,050 radiomics features are extracted from the three feature maps; second, we extracted 37 spectral features from the normalized frequency spectrum after Fourier transform.
We use LASSO regression as the method for feature selection; moreover, we use support vector machine (SVM) for classification 10-fold cross-validation for examining the classification performance of the SVM. An AUC (area under the receiver operating characteristic curve) of 0.84 was obtained on 71 subjects.
Our method is feasible to detect prostate cancer based on the ultrasound RF signal with superior classification performance. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology Edited by: Po-Hsiang Tsui, Chang Gung University, Taiwan Reviewed by: Fajin Dong, Jinan University, China; Reza Mousavi, Nuralogix Corporation, Canada These authors have contributed equally to this work and share first authorship |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2022.946965 |